SENSEX NIFTY

Tablets

May 02, 2015 at 09:55 | Source: PTI
Maharashtra's Food and Drug Administration (FDA) clamped down on the e-commerce major for online sale of prescription drugs
Apr 30, 2015 at 22:07 | Source: CNBC-TV18
After having forayed into smartphones, tabs and even television sets, Micromax today announced the launch of its new laptop-tablet hybrid called quite simply the canvas laptab.
Apr 26, 2015 at 15:46 | Source: Reuters
Nokia sold its phone business to Microsoft last year, but just months after that it launched a new brand-licensed tablet computer, produced under licence by Taiwan's Foxconn, with an intention to follow up with more devices.
Apr 24, 2015 at 17:42 | Source: PTI
Mylan launches generic hepatitis C drug MCompany's Indian arm Mylan Pharmaceuticals has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the countryyHep in India
Apr 10, 2015 at 09:56 | Source: Moneycontrol.com
Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, has received a final approval from USFDA for the oral contraceptive Levonorgestrel/Ethinyl Estradiol Tablets.
Apr 10, 2015 at 09:44 | Source: Moneycontrol.com
Glenmark Generics Inc USA has been granted final approval by the USFDA for the oral contraceptive Levonorgestrel/Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg, the therapeutic equivalent to Lybrel of Wyeth Pharmaceuticals, Inc.
Apr 10, 2015 at 09:21 | Source: PTI
The company said the approval marks Glenmark's 11th oral contraceptive authorised for distribution by the USFDA. It plans to commence shipping of tablets Levonorgestrel and Ethinyl Estradiol, 0.09 mg/0.02mg immediately, stated the filing.
Apr 07, 2015 at 09:42 | Source: Moneycontrol.com
Glenmark Generics Inc. USA, a subsidiary of Glenmark Generic has been granted final ANDA from the USFDA for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5mcg and 1 mg/5 mcg. Glenmark will commence distribution of the product immediately.
Apr 01, 2015 at 16:14 | Source: PTI
The US arm of the company, Lupin Pharmaceuticals Inc, has launched Amlodipine and Valsartan tablets in various strengths in the US market after getting final approval from the United States Food and Drug Administration (USFDA), Lupin said in a statement.
Apr 01, 2015 at 14:20 | Source: Moneycontrol.com
Lupins US subsidiary Lupin Pharmaceuticals has launched its Amlodipine and Valsartan Tablets.
Messages on Tablets »

madrasan

Silver Member

1 Followers

Shasun Pharma  

a license to sell a generic version of Renvela (sevelamer carbonate) 800-mg tablets beginning March 16, 2014. Impax can also sell oral suspension versions of Renvela and Renagel (sevelamer hydrochloride) beginning September 16, 2014.

12.48 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7518 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7518 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7518 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

aindia

Silver Member

193 Followers

Ybrant Digital  

% growth for the first time since 2004, when ad spending increased 6.7%. Mobile will lead this year’s rise in total media ad spending in the US, and advertisers will spend 83.0% more on tablets and smartphones than they did in 2013—an increase of $8.04 billion. By the end of this year, mobile

7.34 PM Jul 2nd 2014

Web Messenger

Platinum Member

283956 Followers

Mobile Tele  

Source:VC Circle - Samsung-Galaxy-Tab-S After unveiling the same last month, Samsung has now launched its Galaxy Tab S range of tablets in the Indian market. The tablets are available in 8.4 and 10.5 inch display screen sizes and according to the company, these are the ...

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

283956 Followers

Mobile Tele  

Source:Money Rediff News Report - Sony's flagship tablet - the Xperia Z2 Tablet - after going on sale in some parts of the world, has now become available in India at an online retailer at a price of Rs. 49,990 for its 4G LTE variant. The tablet is also listed on the official website

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

283956 Followers

Mobile Tele  

Source:Money Rediff News Report - Korean electronics giant Samsung today launched its new tablet 'Tab S' for Rs 37,800 onwards, to further strengthen its position in the Indian market. The device will be available in two screen sizes - 8.4 inch and 10.5 inch - priced at Rs 37,800 and

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

283956 Followers

News Now  

Source:Economic Times - Hybrids and Detachables When Microsoft launched Windows 8 with a touch-optimized interface, a number of manufacturers launched hybrid and detachable devices that offered the benefit of a traditional laptop as well as a tablet. These hybrids are easy to carry around, have

3.12 PM Jul 2nd 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.